DERM stock forecast
Our latest prediction for Dermira, Inc.'s stock price was made on the July 9, 2018 when the stock price was at 10.42$.
In the short term (2weeks), DERM's stock price should outperform the market by 3.78%. During that period the price should oscillate between -10.05% and +14.49%.
In the medium term (3months), DERM's stock price should outperform the market by 3.94%. During that period the price should oscillate between -22.42% and +35.22%.Get email alerts
About Dermira, Inc.
Dermira, Inc. is a biopharmaceutical company, which engages in the provision of therapies for chronic skin conditions. It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis and atopic dermatitis. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Menlo Park, CA.
At the moment the company generates 83M USD in revenues.
On its last earning announcement, the company reported a loss of -4.47$ per share.
The book value per share is 2.68$
Three months stock forecastJuly 9, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|